Wednesday, April 20th, 2016

Alzheimer Companies and Product Overview

AC Immune SA, Acobiom, Acumen Pharmaceuticals, Inc., Adlyfe Inc., Advanced Genomic Technology, LLC, ADx NeuroSciences NV, Akrivis Technologies, LLC, Alere Inc., Alzhyme Pty Ltd, Amarantus Bioscience Holdings, Inc., Applied Proteomics, Inc., Araclon Biotech, S.L. , Banyan Biomarkers, Inc., BioArctic Neuroscience AB, biOasis Technologies Inc., Biomedical Development Corporation, BioSystems International, C2N Diagnostics LLC, Chronix Biomedical, Inc., Cognoptix, Inc. , Columbia University, CompanDX Ltd., Consejo Superior de Investigaciones Cientificas, Cymedx, DiaGenic ASA, DiamiR LLC, DiaPat GmbH, Diaxonhit S.A., Dr. Grossegger & Drbal GmbH and DS Pharma Biomedical Co., Ltd.

Complete research report is available at

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.


  • Extensive coverage of the Alzheimer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Get discount on this research report at

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

File Library

Contact Profile

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect With Us on:  



Twitter: https: //

G+ / Google Plus:



Ritesh Tiwari
P: + 1 888 391 5441


Alzheimer Diagnostic Tests,Alzheimer Diagnostic Tests market,Alzheimer Diagnostic Tests pipeline




More Formats

View QR Code